These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15500127

  • 1. [Focal segmental glomerulosclerosis].
    Yuzawa Y, Matsuo S.
    Nihon Rinsho; 2004 Oct; 62(10):1837-41. PubMed ID: 15500127
    [Abstract] [Full Text] [Related]

  • 2. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
    Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
    Pol J Pathol; 2006 Oct; 57(1):17-21. PubMed ID: 16739878
    [Abstract] [Full Text] [Related]

  • 3. Animal models of FSGS: lessons for pathogenesis and treatment.
    Fogo AB.
    Semin Nephrol; 2003 Mar; 23(2):161-71. PubMed ID: 12704576
    [Abstract] [Full Text] [Related]

  • 4. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N, Damodaran TV, Winn MP.
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [Abstract] [Full Text] [Related]

  • 5. The genetic basis of FSGS and steroid-resistant nephrosis.
    Pollak MR.
    Semin Nephrol; 2003 Mar; 23(2):141-6. PubMed ID: 12704574
    [Abstract] [Full Text] [Related]

  • 6. [The genetic basis of familial focal segmental glomerulosclerosis and related nephrotic syndrome].
    Tsukaguchi H, Kitamura A.
    Nihon Jinzo Gakkai Shi; 2007 Mar; 49(2):88-97. PubMed ID: 17375615
    [No Abstract] [Full Text] [Related]

  • 7. Bigenic heterozygosity and the development of steroid-resistant focal segmental glomerulosclerosis.
    Löwik M, Levtchenko E, Westra D, Groenen P, Steenbergen E, Weening J, Lilien M, Monnens L, van den Heuvel L.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3146-51. PubMed ID: 18443213
    [Abstract] [Full Text] [Related]

  • 8. [Structure and function of the glomerular filtration barrier].
    Musiał K, Zwolińska D.
    Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
    [Abstract] [Full Text] [Related]

  • 9. [Structure and function of podocyte].
    Kawachi H, Miyauchi N, Han GD.
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():70-3. PubMed ID: 16523862
    [No Abstract] [Full Text] [Related]

  • 10. [A genetic viewpoint of focal glomerular sclerosis: fom genes to glomerular pathophysiology [corrected]].
    Aucella F, Bisceglia L, Stallone C.
    G Ital Nefrol; 2003 Feb; 20(4):356-67. PubMed ID: 14523896
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study.
    Goumenos DS, Tsagalis G, El Nahas AM, Shortland JR, Davlouros P, Vlachojannis JG, Brown CB.
    Nephron Clin Pract; 2006 Feb; 104(2):c75-82. PubMed ID: 16785738
    [Abstract] [Full Text] [Related]

  • 12. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
    Hirakawa M, Tsuruya K, Yotsueda H, Tokumoto M, Ikeda H, Katafuchi R, Fujimi S, Hirakata H, Iida M.
    Life Sci; 2006 Jul 17; 79(8):757-63. PubMed ID: 16564554
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of disease: focal segmental glomerulosclerosis.
    Meyrier A.
    Nat Clin Pract Nephrol; 2005 Nov 17; 1(1):44-54. PubMed ID: 16932363
    [Abstract] [Full Text] [Related]

  • 14. [Focal segmental glomerulosclerosis (FSGS). Molecular defects and clinical relevance].
    Schiffer M, Haller H.
    Dtsch Med Wochenschr; 2006 Jul 07; 131(27):1541-5. PubMed ID: 16817104
    [No Abstract] [Full Text] [Related]

  • 15. [Focal segmental glomerulosclerosis (FSGS)].
    Sato H.
    Nihon Jinzo Gakkai Shi; 2010 Jul 07; 52(7):888-93. PubMed ID: 21077336
    [No Abstract] [Full Text] [Related]

  • 16. Molecular basis of steroid-resistant nephrotic syndrome.
    Antignac C.
    Nefrologia; 2005 Jul 07; 25 Suppl 2():25-8. PubMed ID: 16050398
    [Abstract] [Full Text] [Related]

  • 17. R168H and V165X mutant podocin might induce different degrees of podocyte injury via different molecular mechanisms.
    Fan Q, Zhang H, Ding J, Liu S, Miao J, Xing Y, Yu Z, Guan N.
    Genes Cells; 2009 Sep 07; 14(9):1079-90. PubMed ID: 19674119
    [Abstract] [Full Text] [Related]

  • 18. CD2-associated protein and glomerular disease.
    Wolf G, Stahl RA.
    Lancet; 2003 Nov 22; 362(9397):1746-8. PubMed ID: 14643126
    [Abstract] [Full Text] [Related]

  • 19. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS).
    Gigante M, Pontrelli P, Montemurno E, Roca L, Aucella F, Penza R, Caridi G, Ranieri E, Ghiggeri GM, Gesualdo L.
    Nephrol Dial Transplant; 2009 Jun 22; 24(6):1858-64. PubMed ID: 19131354
    [Abstract] [Full Text] [Related]

  • 20. [Molecular mechanism of proteinuria and new therapeutic approach against proteinuria].
    Yuzawa Y.
    Nihon Rinsho; 2006 Feb 22; 64 Suppl 2():355-9. PubMed ID: 16523915
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.